Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Morgan

Showing results (41-50 of 129) with videos related to

Pageof 13
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2Richard A Morgan, James C Yang, Mio Kitano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectorsMichal Lotem, Yangbing Zhao, John Riley, et al.
Cancer Research|April 19, 2007
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCyrille J Cohen, Yong F Li, Mona El-Gamil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2012
Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in miceDhanalakshmi Chinnasamy, Zhiya Yu, Sid P Kerkar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCRCyrille J Cohen, Zhili Zheng, Regina Bray, et al.
Blood|July 18, 2013
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytesDaniel Abate-Daga, Ken-ichi Hanada, Jeremy L Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trialsJeremy L Davis, Marc R Theoret, Zhili Zheng, et al.
Cancer Immunology, Immunotherapy : CII|December 5, 2012
Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktailsShicheng Yang, Yun Ji, Luca Gattinoni, et al.
The Journal of Experimental Medicine|May 29, 2013
Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexiaEric Tran, Dhanalakshmi Chinnasamy, Zhiya Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 3, 2011
Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environmentLing Zhang, Sid P Kerkar, Zhiya Yu, et al.
Pageof 13

Showing results (41-50 of 129) with videos related to

Sort By:
Pageof 13
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 25, 2010
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2Richard A Morgan, James C Yang, Mio Kitano, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectorsMichal Lotem, Yangbing Zhao, John Riley, et al.
Cancer Research|April 19, 2007
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bondCyrille J Cohen, Yong F Li, Mona El-Gamil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2012
Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in miceDhanalakshmi Chinnasamy, Zhiya Yu, Sid P Kerkar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Recognition of fresh human tumor by human peripheral blood lymphocytes transduced with a bicistronic retroviral vector encoding a murine anti-p53 TCRCyrille J Cohen, Zhili Zheng, Regina Bray, et al.
Blood|July 18, 2013
Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytesDaniel Abate-Daga, Ken-ichi Hanada, Jeremy L Davis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trialsJeremy L Davis, Marc R Theoret, Zhili Zheng, et al.
Cancer Immunology, Immunotherapy : CII|December 5, 2012
Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktailsShicheng Yang, Yun Ji, Luca Gattinoni, et al.
The Journal of Experimental Medicine|May 29, 2013
Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexiaEric Tran, Dhanalakshmi Chinnasamy, Zhiya Yu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 3, 2011
Improving adoptive T cell therapy by targeting and controlling IL-12 expression to the tumor environmentLing Zhang, Sid P Kerkar, Zhiya Yu, et al.
Pageof 13